Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
Yasar
Tekin
T
Ozdemir
Murat
M
Andi
Inayet
I
Ozdemir
Gokhan
G
Simsek
Saban
S
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002354:Carteolol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy; D010349:Patient Compliance; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost; D002354:Carteolol